Brokerages Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.13

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has received an average rating of "Hold" from the five analysts that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $5.20.

Several equities analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a report on Friday, June 27th. Truist Financial reduced their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group raised their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th. Finally, Barclays assumed coverage on shares of Aveanna Healthcare in a research note on Wednesday. They issued an "equal weight" rating and a $5.50 price target on the stock.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH traded up $0.17 during mid-day trading on Wednesday, hitting $4.63. The company had a trading volume of 480,689 shares, compared to its average volume of 342,245. Aveanna Healthcare has a 12 month low of $2.48 and a 12 month high of $6.19. The stock has a market cap of $902.29 million, a price-to-earnings ratio of 231.25 and a beta of 1.98. The firm's 50 day simple moving average is $5.16 and its two-hundred day simple moving average is $4.87.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the company's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the sale, the insider directly owned 29,640,756 shares of the company's stock, valued at approximately $158,874,452.16. This represents a 5.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, major shareholder Robert M. Williams, Jr. sold 1,560,700 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the sale, the insider directly owned 29,640,756 shares in the company, valued at approximately $158,874,452.16. The trade was a 5.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,115,345 shares of company stock worth $37,838,057 over the last ninety days. Insiders own 7.80% of the company's stock.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently modified their holdings of the company. Banque Transatlantique SA acquired a new position in Aveanna Healthcare during the first quarter worth about $25,000. KLP Kapitalforvaltning AS acquired a new position in shares of Aveanna Healthcare in the 4th quarter worth approximately $35,000. BNP Paribas Financial Markets acquired a new position in shares of Aveanna Healthcare in the 4th quarter worth approximately $35,000. Tower Research Capital LLC TRC raised its holdings in shares of Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after purchasing an additional 6,854 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd lifted its stake in Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock valued at $54,000 after purchasing an additional 9,000 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.